Log in to save to my catalogue

Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals

Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b795688a74a048bcb40712b38d7070cf

Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals

About this item

Full title

Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals

Publisher

England: eLife Sciences Publications Ltd

Journal title

eLife, 2016-11, Vol.5

Language

English

Formats

Publication information

Publisher

England: eLife Sciences Publications Ltd

More information

Scope and Contents

Contents

Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disease caused by mutations in
(
). Loss of
causes impaired mitochondrial function and iron homeostasis. An elevated production of reactive oxygen species (ROS) was previously proposed to contribute to the pathogenesis of FRDA. We recently showed that loss of
(
),...

Alternative Titles

Full title

Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b795688a74a048bcb40712b38d7070cf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b795688a74a048bcb40712b38d7070cf

Other Identifiers

ISSN

2050-084X

E-ISSN

2050-084X

DOI

10.7554/eLife.20732

How to access this item